Global Artificial Pancreas Device Systems Market Report and Forecast 2024-2032

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology                  
2    Executive Summary
3    Global Artificial Pancreas Device Systems Market Overview 
    3.1     Global Artificial Pancreas Device Systems Market Historical Value (2017-2023) 
    3.2     Global Artificial Pancreas Device Systems Market Forecast Value (2024-2032)
4     Global Artificial Pancreas Device Systems Market Landscape*
    4.1     Global Artificial Pancreas Device Systems Market: Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2     Global Artificial Pancreas Device Systems Market: Product Landscape
        4.2.1    Analysis by Device Type
5    Global Artificial Pancreas Device Systems Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
        5.2.1    Strengths
        5.2.2    Weaknesses
        5.2.3    Opportunities
        5.2.4    Threats
    5.3    Porter’s Five Forces Model
        5.3.1    Bargaining Power of Suppliers
        5.3.2    Bargaining Power of Buyers
        5.3.3    Threat of New Entrants
        5.3.4    Threat of Substitutes
        5.3.5    Degree of Rivalry
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6     Global Artificial Pancreas Device Systems Market Segmentation (2017-2032)
    6.1     Global Artificial Pancreas Device Systems Market (2017-2032) by Device Type
        6.1.1    Market Overview
        6.1.2    Threshold Suspend Device Systems
        6.1.3    Control-to-Range (CTR) Systems
        6.1.4    Control-to-Target (CTT) Systems
    6.2    Global Artificial Pancreas Device Systems Market (2017-2032) by End User
        6.2.1    Hospitals 
        6.2.2    Clinics
        6.2.3    Others    
    6.3     Global Artificial Pancreas Device Systems Market (2017-2032) by Region
        6.3.1    Market Overview
        6.3.2    North America
        6.3.3    Europe 
        6.3.4    Asia Pacific
        6.3.5    Latin America
        6.3.6    Middle East and Africa
7    North America Artificial  Pancreas Device Systems Market (2017-2032)
    7.1     North America Artificial Pancreas Device Systems Market (2017-2032) by Device Type
        7.1.1    Market Overview
        7.1.2    Threshold Suspend Device Systems
        7.1.3    Control-to-Range (CTR) Systems
        7.1.4    Control-to-Target (CTT) Systems
    7.2    North America Artificial Pancreas Device Systems Market (2017-2032) by End User
        7.2.1    Hospitals 
        7.2.2    Clinics
        7.2.3    Others
    7.3    North America Artificial Pancreas Device Systems Market (2017-2032) by Country
        7.3.1    United States of America
        7.3.2    Canada
8    Europe Artificial Pancreas Device Systems Market (2017-2032)
    8.1     Europe Artificial Pancreas Device Systems Market (2017-2032) by Device Type
        8.1.1    Market Overview
        8.1.2    Threshold Suspend Device Systems
        8.1.3    Control-to-Range (CTR) Systems
        8.1.4    Control-to-Target (CTT) Systems
    8.2    Europe Artificial Pancreas Device Systems Market (2017-2032) by End User
        8.2.1    Hospitals 
        8.2.2    Clinics
        8.2.3    Others
    8.3    Europe Artificial Pancreas Device Systems Market (2017-2032) by Country
        8.3.1    United Kingdom
        8.3.2    Germany
        8.3.3    France
        8.3.4    Italy
        8.3.5    Others
9    Asia Pacific Artificial Pancreas Device Systems Market (2017-2032)
    9.1    Asia Pacific Artificial Pancreas Device Systems Market (2017-2032) by Device Type
        9.1.1    Market Overview
        9.1.2    Threshold Suspend Device Systems
        9.1.3    Control-to-Range (CTR) Systems
        9.1.4    Control-to-Target (CTT) Systems
    9.2    Asia Pacific Artificial Pancreas Device Systems Market (2017-2032) by End User
        9.2.1    Hospitals 
        9.2.2    Clinics
        9.2.3    Others
    9.3    Asia Pacific Artificial Pancreas Device Systems Market (2017-2032) by Country
        9.3.1    China
        9.3.2    Japan
        9.3.3    India
        9.3.4    ASEAN
        9.3.5    Australia
        9.3.6    Others
10    Latin America Artificial Pancreas Device Systems Market (2017-2032)
    10.1       Latin America Artificial Pancreas Device Systems Market (2017-2032) by Device Type
        10.1.1    Market Overview
        10.1.2    Threshold Suspend Device Systems
        10.1.3    Control-to-Range (CTR) Systems
        10.1.4    Control-to-Target (CTT) Systems
    10.2    Latin America Artificial Pancreas Device Systems Market (2017-2032) by End User
        10.2.1    Hospitals 
        10.2.2    Clinics
        10.2.3    Others
    10.3     Latin America Artificial Pancreas Device Systems Market (2017-2032) by Country
        10.3.1    Brazil
        10.3.2    Argentina
        10.3.3    Mexico
        10.3.4    Others
11    Middle East and Africa Artificial Pancreas Device Systems Market (2017-2032)
    11.1      Middle East and Africa Artificial Pancreas Device Systems Market (2017-2032) by Device Type
        11.1.1    Market Overview
        11.1.2    Threshold Suspend Device Systems
        11.1.3    Control-to-Range (CTR) Systems
        11.1.4    Control-to-Target (CTT) Systems
    11.2    Middle East and Africa Artificial Pancreas Device Systems Market (2017-2032) by End User
        11.2.1    Hospitals 
        11.2.2    Clinics
        11.2.3    Others
    11.3     Middle East and Africa Artificial Pancreas Device Systems Market (2017-2032) by Country
        11.3.1    Saudi Arabia
        11.3.2    United Arab Emirates
        11.3.3    Nigeria
        11.3.4    South Africa
        11.3.5    Others
12    Regulatory  Framework
    12.1     Regulatory Overview
        12.1.1    US FDA
        12.1.2    EU EMA
        12.1.3    INDIA CDSCO
        12.1.4    JAPAN PMDA
        12.1.5    Others
13    Patent Analysis
    13.1     Analysis by Component of Patent
    13.2     Analysis by Publication year
    13.3     Analysis by Issuing Authority
    13.4     Analysis by Patent Age
    13.5     Analysis by CPC Analysis
    13.6     Analysis by Patent Valuation 
    13.7     Analysis by Key Players
14    Grants Analysis
    14.1     Analysis by Year
    14.2     Analysis by Amount Awarded
    14.3     Analysis by Issuing Authority
    14.4     Analysis by Grant Product
    14.5     Analysis by Funding Institute
    14.6     Analysis by Departments
    14.7     Analysis by Recipient Organization 
15    Funding  and Investment Analysis
    15.1     Analysis by Funding Instances
    15.2     Analysis by Component of Funding
    15.3     Analysis by Funding Amount
    15.4     Analysis by Leading Players
    15.5     Analysis by Leading Investors
    15.6     Analysis by Geography
16    Partnership and Collaborations Analysis
    16.1     Analysis by Partnership Instances
    16.2     Analysis by Component of Partnership
    16.3     Analysis by Leading Players
    16.4     Analysis by Geography
17    Supplier Landscape
    17.1    Market Share by Top 5 Companies
    17.2    Medtronic
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications 
    17.3    EOFLOW CO., LTD
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Beta Bionics
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Tandem Diabetes Care, Inc.
        17.5.1     Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Insulet Corporation
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Dexcom
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Medtrum Technologies Inc.
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Nikkiso Co., Ltd.
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Pancreum, Inc.
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    Abbott
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications 
    17.12    Admetsys Corporation
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications                     
    17.13    INREDA® DIABETIC B.V.
        17.13.1    Financial Analysis
        17.13.2    Product Portfolio
        17.13.3    Demographic Reach and Achievements
        17.13.4    Mergers and Acquisitions
        17.13.5    Certifications                 
    17.14    Diabeloop SA 
        17.14.1    Financial Analysis
        17.14.2    Product Portfolio
        17.14.3    Demographic Reach and Achievements
        17.14.4    Mergers and Acquisitions
        17.14.5    Certifications
18    Global Artificial Pancreas Device Systems Market – Distribution Model (Additional Insight)
    18.1     Overview 
    18.2     Potential Distributors 
    18.3     Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)
    20.1     Very Small Companies
    20.2     Small Companies
    20.3     Mid-Sized Companies
    20.4     Large Companies
    20.5     Very Large Companies
21    Payment Methods (Additional Insight)
    21.1     Government Funded
    21.2     Private Insurance
    21.3     Out-of-Pocket

*Additional insights provided are customisable as per client requirements.

* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.